
Tattoo ink could be key to detecting cancer early
USC research has uncovered that commonly used coloring agents like tattoo inks and food dyes can illuminate cancer cells, differentiating them from normal adjacent cells.
USC research has uncovered that commonly used coloring agents like tattoo inks and food dyes can illuminate cancer cells, differentiating them from normal adjacent cells.
The guidelines evaluate existing research and treatment options for clinicians and patients to maximize lymphedema volume-reducing treatment.
Inspired by his father’s fight against non-Hodgkin’s lymphoma, Remo Rohs leads USC’s efforts in studying the molecular nature of cancer.
USC researchers are using AI to fuel more confident diagnosis of renal tumors, as well as more customized treatment for cancer patients and patients infected with COVID-19.
The tool, developed by USC researchers, could help identify patients with the most to gain from a clinical trial as well as guide therapeutic targets.
The renowned oncologist and cancer researcher will join USC in this newly created position in September.
A USC-led team of international scientists found that a one-two punch of a fasting-mimicking diet with hormone therapy may enhance the effects of breast cancer treatment.
A Keck Medicine of USC study found that socioeconomic status plays an important role in access to chemotherapy.
The gift creates and supports the Rosalie and Harold Rae Brown Center for Cancer Drug Discovery, which will focus on accelerating the development of groundbreaking cancer treatments.
Chemical engineers at USC Viterbi have unlocked a fatal vulnerability in many cancer cells: sugar inflexibility.
Computational models developed by USC researchers indicate that keeping tumor cells in competition can lead to more effective cancer treatments.
According to a new USC study, roughly 12% of men of African ancestry carry a variant in their genome that increases their prostate cancer risk twofold.
The current way to make a highly targeted type of drug called “antibody-drug conjugates” is lengthy and inefficient. Scientists at the USC School of Pharmacy have engineered something better.
A USC study found that a combination of a fasting-mimicking diet plus vitamin C delayed tumor progression and even caused disease regression in mice.
The grant of nearly $5 million to USC Stem Cell scientist Min Yu recognizes her innovative work with rare circulating tumor cells.
Ebony Flowers, a postdoctoral fellow at USC Stem Cell, will use the support from the fellowship to further study the role of free radicals in breast cancer.
Ryan Melendez has raised more than $500,000 for pediatric cancer through Warrior Horses for Warrior Kids.
These everyday heroes use math and networks to make a difference in the world.
Having a wider array of people participating in medical research is crucial to advancing care for all patients.
To understand how cancer spreads to the brain, Josh Neman looks for answers in his lab—with inspiration from patients.
A USC pilot study — the first clinical trial of this drug in cancer patients — reported lower prostate-specific antigen levels in more than half of the participants.
According to scientists at the Keck School of Medicine of USC, the chemical alterations in people who vape are similar to those found in cigarette smokers.
Between childhood and adulthood, young people with cancer may feel ignored and misunderstood — but USC researchers won’t let them be forgotten.
Patient Richard Johannesen shares how USC physical therapist Daniel Kirages helped him deal with the effects of cancer therapy.